136 related articles for article (PubMed ID: 38556793)
1. CRISPR-Cas9n-mediated ELANE promoter editing for gene therapy of severe congenital neutropenia.
Nasri M; Ritter MU; Mir P; Dannenmann B; Kaufmann MM; Arreba-Tutusaus P; Xu Y; Borbaran-Bravo N; Klimiankou M; Lengerke C; Zeidler C; Cathomen T; Welte K; Skokowa J
Mol Ther; 2024 Jun; 32(6):1628-1642. PubMed ID: 38556793
[TBL] [Abstract][Full Text] [Related]
2. CRISPR-Cas9-Mediated ELANE Mutation Correction in Hematopoietic Stem and Progenitor Cells to Treat Severe Congenital Neutropenia.
Tran NT; Graf R; Wulf-Goldenberg A; Stecklum M; Strauß G; Kühn R; Kocks C; Rajewsky K; Chu VT
Mol Ther; 2020 Dec; 28(12):2621-2634. PubMed ID: 32822592
[TBL] [Abstract][Full Text] [Related]
3. CRISPR/Cas9-mediated
Nasri M; Ritter M; Mir P; Dannenmann B; Aghaallaei N; Amend D; Makaryan V; Xu Y; Fletcher B; Bernhard R; Steiert I; Hahnel K; Berger J; Koch I; Sailer B; Hipp K; Zeidler C; Klimiankou M; Bajoghli B; Dale DC; Welte K; Skokowa J
Haematologica; 2020 Mar; 105(3):598-609. PubMed ID: 31248972
[TBL] [Abstract][Full Text] [Related]
4. Differential transcriptional control of hematopoiesis in congenital and cyclic neutropenia patients harboring
Zeidler A; Borbaran-Bravo N; Dannenmann B; Ritter M; Nasri M; Klimiankou M; Kandabarau S; Zahabi A; König J; Zeidler C; Skokowa J; Welte K
Haematologica; 2024 May; 109(5):1393-1402. PubMed ID: 37855057
[TBL] [Abstract][Full Text] [Related]
5. ELANE mutations in cyclic and severe congenital neutropenia: genetics and pathophysiology.
Horwitz MS; Corey SJ; Grimes HL; Tidwell T
Hematol Oncol Clin North Am; 2013 Feb; 27(1):19-41, vii. PubMed ID: 23351986
[TBL] [Abstract][Full Text] [Related]
6. The spectrum of ELANE mutations and their implications in severe congenital and cyclic neutropenia.
Germeshausen M; Deerberg S; Peter Y; Reimer C; Kratz CP; Ballmaier M
Hum Mutat; 2013 Jun; 34(6):905-14. PubMed ID: 23463630
[TBL] [Abstract][Full Text] [Related]
7. Dissecting ELANE neutropenia pathogenicity by human HSC gene editing.
Rao S; Yao Y; Soares de Brito J; Yao Q; Shen AH; Watkinson RE; Kennedy AL; Coyne S; Ren C; Zeng J; Serbin AV; Studer S; Ballotti K; Harris CE; Luk K; Stevens CS; Armant M; Pinello L; Wolfe SA; Chiarle R; Shimamura A; Lee B; Newburger PE; Bauer DE
Cell Stem Cell; 2021 May; 28(5):833-845.e5. PubMed ID: 33513358
[TBL] [Abstract][Full Text] [Related]
8. Severe congenital neutropenia with elastase, neutrophil expressed (ELANE) gene mutation in a Tanzanian child.
Shoo A; Swai P; Kindole C; Ngailo E; Godfrey E; Massawe E; Warren AJ; Luzzatto L
Br J Haematol; 2022 Mar; 196(5):1271-1274. PubMed ID: 34725814
[No Abstract] [Full Text] [Related]
9. Inducible expression of a disease-associated
Garg B; Mehta HM; Wang B; Kamel R; Horwitz MS; Corey SJ
J Biol Chem; 2020 May; 295(21):7492-7500. PubMed ID: 32299910
[TBL] [Abstract][Full Text] [Related]
10. PML-controlled responses in severe congenital neutropenia with ELANE-misfolding mutations.
Olofsen PA; Bosch DA; Roovers O; van Strien PMH; de Looper HWJ; Hoogenboezem RM; Barnhoorn S; Mastroberardino PG; Ghazvini M; van der Velden VHJ; Bindels EMJ; de Pater EM; Touw IP
Blood Adv; 2021 Feb; 5(3):775-786. PubMed ID: 33560392
[TBL] [Abstract][Full Text] [Related]
11. Severe congenital neutropenia in a multigenerational family with a novel neutrophil elastase (ELANE) mutation.
van de Vosse E; Verhard EM; Tool AJ; de Visser AW; Kuijpers TW; Hiemstra PS; van Dissel JT
Ann Hematol; 2011 Feb; 90(2):151-8. PubMed ID: 20803142
[TBL] [Abstract][Full Text] [Related]
12. Congenital neutropenia: From lab bench to clinic bedside and back.
Dobrewa W; Bielska M; Bąbol-Pokora K; Janczar S; Młynarski W
Mutat Res Rev Mutat Res; 2024; 793():108476. PubMed ID: 37989463
[TBL] [Abstract][Full Text] [Related]
13. Clinical characteristics of severe congenital neutropenia caused by novel ELANE gene mutations.
Shu Z; Li XH; Bai XM; Zhang ZY; Jiang LP; Tang XM; Zhao XD
Pediatr Infect Dis J; 2015 Feb; 34(2):203-7. PubMed ID: 25162927
[TBL] [Abstract][Full Text] [Related]
14. Neutrophil Elastase Defects in Congenital Neutropenia.
Rydzynska Z; Pawlik B; Krzyzanowski D; Mlynarski W; Madzio J
Front Immunol; 2021; 12():653932. PubMed ID: 33968054
[TBL] [Abstract][Full Text] [Related]
15. Severe congenital neutropenia.
Welte K; Zeidler C; Dale DC
Semin Hematol; 2006 Jul; 43(3):189-95. PubMed ID: 16822461
[TBL] [Abstract][Full Text] [Related]
16. [Clinical and genetic analysis of two patients with congenital neutropenia caused by ELANE gene mutation].
Liu H; Liu G; Zhao P; Huang L; Zhou Y; Qiu X; Xu L
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2020 Oct; 37(10):1097-1101. PubMed ID: 32924109
[TBL] [Abstract][Full Text] [Related]
17. Functional characteristics of circulating granulocytes in severe congenital neutropenia caused by ELANE mutations.
Liu Q; Sundqvist M; Li W; Holdfeldt A; Zhang L; Björkman L; Bylund J; Dahlgren C; Wang C; Zhao X; Forsman H
BMC Pediatr; 2019 Jun; 19(1):189. PubMed ID: 31176364
[TBL] [Abstract][Full Text] [Related]
18. A Truncated Granulocyte Colony-stimulating Factor Receptor (G-CSFR) Inhibits Apoptosis Induced by Neutrophil Elastase G185R Mutant: IMPLICATION FOR UNDERSTANDING CSF3R GENE MUTATIONS IN SEVERE CONGENITAL NEUTROPENIA.
Qiu Y; Zhang Y; Hu N; Dong F
J Biol Chem; 2017 Feb; 292(8):3496-3505. PubMed ID: 28073911
[TBL] [Abstract][Full Text] [Related]
19. Novel ELANE gene mutation in a Korean girl with severe congenital neutropenia.
Shim YJ; Kim HJ; Suh JS; Lee KS
J Korean Med Sci; 2011 Dec; 26(12):1646-9. PubMed ID: 22148006
[TBL] [Abstract][Full Text] [Related]
20. Congenital Neutropenia and Rare Functional Phagocyte Disorders in Children.
Walkovich K; Connelly JA
Hematol Oncol Clin North Am; 2019 Jun; 33(3):533-551. PubMed ID: 31030818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
